(Q43945790)

28 November 2017

title

Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine (English)

1 reference

28 November 2017

Athina Pyrpasopoulou

2

0 references

Areti Triantafyllou

series ordinal

4

object named as

Areti Triantafyllou

1 reference

28 November 2017

3

Stella Douma

1 reference

28 November 2017

1

Spyros Aslanidis

1 reference

28 November 2017

publication date

10 November 2007

1 reference

28 November 2017

published in

Clinical Rheumatology

1 reference

28 November 2017

volume

27

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

377-380

1 reference

Glucocorticoid-induced TNF receptor functions as a costimulatory receptor that promotes survival in early phases of T cell activation.

28 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-007-0789-5

The role of lesional T cells in recalcitrant psoriasis during infliximab therapy

21 January 2018

1 reference

12 December 2020

Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series

1 reference

12 December 2020

Autoimmunity through cytokine-induced dendritic cell activation

1 reference

12 December 2020

Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

1 reference

12 December 2020

Psoriatic arthritis assessment tools in clinical trials

1 reference

12 December 2020

Psoriatic arthritis treatment: biological response modifiers

1 reference

12 December 2020

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

12 December 2020

A randomized trial of etanercept as monotherapy for psoriasis.

1 reference

12 December 2020

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

1 reference

12 December 2020

Infliximab can precipitate as well as worsen palmoplantar pustulosis: possible linkage to the expression of tumour necrosis factor-alpha in the normal palmar eccrine sweat duct?

1 reference

12 December 2020

Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study

1 reference

12 December 2020

Psoriasis pathophysiology: current concepts of pathogenesis

1 reference

12 December 2020

Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor

1 reference

12 December 2020

Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors

1 reference

12 December 2020

New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression

1 reference

12 December 2020

New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?

1 reference

12 December 2020

Anti-tumor necrosis factor-alpha-induced psoriasis

1 reference

12 December 2020

Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction

1 reference

12 December 2020

1 reference

12 December 2020

Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis

1 reference

12 December 2020

Anti-TNF-alpha-induced psoriasis: case report of an unusual adverse event

1 reference

12 December 2020

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)

1 reference

12 December 2020

Anti-tumor necrosis factor alpha-induced psoriasiform eruptions: three further cases and current overview

1 reference

12 December 2020

The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis

1 reference

12 December 2020

10.1007/S10067-007-0789-5

Identifiers

DOI

1 reference

28 November 2017

1 reference